# Lion Point Capital, LP 13F holdings Q2 2026: $20.9 million

Lion Point Capital, LP reported $20.9 million in 13F securities across 35 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Cue Biopharma Inc at $1.7 million, 8.0% of the reported value. Since Q1 2026 it opened 1 new position and exited 1.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $20,905,264
- Positions: 35
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1643354
- Form 13F file number: 028-17316
- CRD number: 174322
- Business address: 375 Park Ave Suite 2609, New York, NY 10152
- SEC filing: [0001013594-26-000908](https://www.sec.gov/Archives/edgar/data/1643354/000101359426000908/0001013594-26-000908-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/lion-point-capital-lp-174322)

## Top 25 holdings by value

The largest of 35 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Cue Biopharma Inc](https://specstream.ai/data/institutional-holders/cue-biopharma-inc-22978p205) | COM | 52,928 | $1.7 million | New |
| [Praxis Precision Medicines I](https://specstream.ai/data/institutional-holders/praxis-precision-medicines-i-74006w207) | COM NEW | 4,450 | $1.5 million | No change |
| [Moonlake Immunotherapeutics](https://specstream.ai/data/institutional-holders/moonlake-immunotherapeutics-61559x104) | CLASS A ORD | 67,500 | $1.3 million | No change |
| [Fennec Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/fennec-pharmaceuticals-inc-31447p100) | COM | 112,434 | $1.2 million | No change |
| [Royalty Pharma PLC](https://specstream.ai/data/institutional-holders/royalty-pharma-plc-g7709q104) | SHS CLASS A | 21,400 | $1.2 million | No change |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 80,000 | $1.1 million | No change |
| [Milestone Pharmaceuticals in](https://specstream.ai/data/institutional-holders/milestone-pharmaceuticals-in-59935v107) | COM | 820,000 | $1.1 million | No change |
| [Benitec Biopharma Inc](https://specstream.ai/data/institutional-holders/benitec-biopharma-inc-08205p209) | COM NEW | 62,000 | $829,560 | No change |
| [Syndax Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/syndax-pharmaceuticals-inc-87164f105) | COM | 36,000 | $786,960 | No change |
| [Biohaven LTD](https://specstream.ai/data/institutional-holders/biohaven-ltd-g1110e107) | COM | 51,700 | $769,296 | No change |
| [Geron Corp](https://specstream.ai/data/institutional-holders/geron-corp-374163103) | COM | 578,000 | $739,840 | No change |
| [Uniqure NV](https://specstream.ai/data/institutional-holders/uniqure-nv-n90064101) | SHS | 14,700 | $677,082 | No change |
| [Ardelyx Inc](https://specstream.ai/data/institutional-holders/ardelyx-inc-039697107) | COM | 128,650 | $656,115 | No change |
| [Lantheus Hldgs Inc](https://specstream.ai/data/institutional-holders/lantheus-hldgs-inc-516544103) | COM | 5,500 | $610,170 | No change |
| [Disc Medicine Inc](https://specstream.ai/data/institutional-holders/disc-medicine-inc-254604101) | COM | 8,100 | $592,434 | No change |
| [Sarepta Therapeutics Inc](https://specstream.ai/data/institutional-holders/sarepta-therapeutics-inc-803607100) | COM | 28,500 | $512,145 | No change |
| [Humacyte Inc](https://specstream.ai/data/institutional-holders/humacyte-inc-44486q103) | COM | 650,000 | $507,260 | No change |
| [Kura Oncology Inc](https://specstream.ai/data/institutional-holders/kura-oncology-inc-50127t109) | COM | 46,000 | $504,620 | No change |
| [Viatris Inc](https://specstream.ai/data/institutional-holders/viatris-inc-92556v106) | COM | 27,700 | $439,876 | No change |
| [Dyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/dyne-therapeutics-inc-26818m108) | COM | 18,000 | $399,780 | No change |
| [Bridgebio Pharma Inc](https://specstream.ai/data/institutional-holders/bridgebio-pharma-inc-10806x102) | COM | 5,000 | $372,400 | No change |
| [Edgewise Therapeutics Inc](https://specstream.ai/data/institutional-holders/edgewise-therapeutics-inc-28036f105) | COM | 9,100 | $369,733 | No change |
| [Pacira Biosciences Inc](https://specstream.ai/data/institutional-holders/pacira-biosciences-inc-695127100) | COM | 13,500 | $342,495 | No change |
| [Regenxbio Inc](https://specstream.ai/data/institutional-holders/regenxbio-inc-75901b107) | COM | 26,600 | $318,668 | No change |
| [Rocket Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/rocket-pharmaceuticals-inc-77313f106) | COM | 86,000 | $294,120 | No change |

## New positions in Q2 2026

1 position not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Cue Biopharma Inc](https://specstream.ai/data/institutional-holders/cue-biopharma-inc-22978p205) | COM | 52,928 | $1.7 million |

## Positions exited in Q2 2026

1 position in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Cue Biopharma Inc | COM | 2,202,854 | $506,436 |

## Also on SpecStream

- [Lion Point Capital, LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1643354/000101359426000908/0001013594-26-000908-index.htm)
- [Lion Point Capital, LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/lion-point-capital-lp-174322)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Waste collection companies in New York, New York](https://specstream.ai/data/businesses/waste-collection-companies/new-york-new-york-united-states)
- [Art schools in New York, New York](https://specstream.ai/data/businesses/art-schools/new-york-new-york-united-states)
- [Broadcast media production companies in New York, New York](https://specstream.ai/data/businesses/broadcast-media-production-companies/new-york-new-york-united-states)
- [Cleaning companies in New York, New York](https://specstream.ai/data/businesses/cleaning-companies/new-york-new-york-united-states)
- [Cuban restaurants in New York, New York](https://specstream.ai/data/businesses/cuban-restaurants/new-york-new-york-united-states)
- [Elementary schools in New York, New York](https://specstream.ai/data/businesses/elementary-schools/new-york-new-york-united-states)
